These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12944921)

  • 1. Use of adeno-associated viral vector for delivery of small interfering RNA.
    Tomar RS; Matta H; Chaudhary PM
    Oncogene; 2003 Aug; 22(36):5712-5. PubMed ID: 12944921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral delivery of small interfering RNA into primary cells.
    Barton GM; Medzhitov R
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14943-5. PubMed ID: 12417750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells.
    Liu XD; Ma SM; Liu Y; Liu SZ; Sehon A
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1173-8. PubMed ID: 15504337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.
    Kaykas A; Moon RT
    BMC Cell Biol; 2004 Apr; 5():16. PubMed ID: 15119963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
    Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
    J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of lentiviral vectors for delivery of small interfering RNA.
    Matta H; Hozayev B; Tomar R; Chugh P; Chaudhary PM
    Cancer Biol Ther; 2003; 2(2):206-10. PubMed ID: 12750565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.
    Schubert S; Grunert HP; Zeichhardt H; Werk D; Erdmann VA; Kurreck J
    J Mol Biol; 2005 Feb; 346(2):457-65. PubMed ID: 15670596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
    Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
    Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA for experimental cancer therapy.
    Tong AW; Zhang YA; Nemunaitis J
    Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
    Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
    J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of transforming growth factor β1 in lung alveolar epithelium-derived cells using adeno-associated virus type 2/5 vectors to carry short hairpin RNA.
    Kage H; Sugimoto K; Sano A; Kitagawa H; Nagase T; Ohishi N; Takai D
    Exp Lung Res; 2011 Apr; 37(3):175-85. PubMed ID: 21269064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.
    Miyagishi M; Taira K
    Nat Biotechnol; 2002 May; 20(5):497-500. PubMed ID: 11981564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vectors for short hairpin RNA expression.
    Grimm D; Pandey K; Kay MA
    Methods Enzymol; 2005; 392():381-405. PubMed ID: 15644194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral delivery of recombinant short hairpin RNAs.
    Davidson BL; Harper SQ
    Methods Enzymol; 2005; 392():145-73. PubMed ID: 15644180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.